An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report

An epidermal growth factor receptor compound mutation of L858R with S768I in advanced non-small-cell lung cancer: a case report

Abstract Background In the current treatment landscape for non-small cell lung cancers, epidermal growth factor receptor-tyrosine kinase inhibitors have emerged as a well-established treatment option for patients with advanced or metastatic disease. This is particularly true for those with commonly...

Full description

Bibliographic Details
Main Authors: Sara Boukansa, Ismail Mouhrach, Fatima El Agy, Laila Bouguenouch, Mounia Serraj, Bouchra Amara, Yassine Ouadnouni, Mohamed Smahi, Badreeddine Alami, Nawfel Mellas, Zineb Benbrahim, Hinde El Fatemi
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Journal of Medical Case Reports
Subjects:
EGFR mutation
L858R
S768I
Afatinib
Case report
Online Access:https://doi.org/10.1186/s13256-024-04422-5

Internet

https://doi.org/10.1186/s13256-024-04422-5

Similar Items